0

524711

VISTAPH

img img img img
No Data Available

VISTA PHARMACEUTICALS LTD. Share Price Update

As of the latest trading session, VISTA PHARMACEUTICALS LTD. is trading at ₹7.9, down by ₹-0.04 or -0.50% from its previous close. The stock has moved between ₹7.63 and ₹8.10 today. Over the past year, the stock has delivered a return of -28.66%. In the last month, it has returned 26.67%.

Investment Returns

Over 1 Month 26.67% Over 3 Months 7.50% Over 6 Months -19.54% Over 1 Year -28.66%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VISTA PHARMACEUTICALS LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 48.60
  • P/E Ratio (TTM) -6.36
  • Beta 0.85
  • Book Value / share 7.25
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -2.32
info icon alternate text

VISTA PHARMACEUTICALS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 2.42
Operating Expense 5.79
Net Profit -2.32
Net Profit Margin (%) -95.86
Earnings Per Share (EPS) -0.41
EBITDA -2.90
Effective Tax Rate (%) 29.26
Particulars SEP 2025 (Values in Cr)
Revenue 1.46
Operating Expense 5.27
Net Profit -2.59
Net Profit Margin (%) -177.39
Earnings Per Share (EPS) -0.42
EBITDA -3.23
Effective Tax Rate (%) 28.45
Particulars JUN 2025 (Values in Cr)
Revenue 1.52
Operating Expense 3.00
Net Profit -1.29
Net Profit Margin (%) -84.86
Earnings Per Share (EPS) -0.22
EBITDA -1.11
Effective Tax Rate (%) 12.83
Particulars MAR 2025 (Values in Cr)
Revenue 3.23
Operating Expense 4.54
Net Profit -1.50
Net Profit Margin (%) -46.43
Earnings Per Share (EPS) -0.79
EBITDA -0.67
Effective Tax Rate (%) -40.56
Particulars DEC 2024 (Values in Cr)
Revenue 2.56
Operating Expense 4.47
Net Profit -1.32
Net Profit Margin (%) -51.56
Earnings Per Share (EPS) -0.07
EBITDA -1.39
Effective Tax Rate (%) 26.66
Particulars MAR 2025 (Values in Cr)
Revenue 10.07
Operating Expense 15.80
Net Profit -4.65
Net Profit Margin (%) -46.17
Earnings Per Share (EPS) -0.79
EBITDA -3.59
Effective Tax Rate (%) 12.09
Particulars MAR 2024 (Values in Cr)
Revenue 10.29
Operating Expense 15.80
Net Profit -4.51
Net Profit Margin (%) -43.82
Earnings Per Share (EPS) -1.03
EBITDA -3.24
Effective Tax Rate (%) 12.93
Particulars MAR 2023 (Values in Cr)
Revenue 1.00
Operating Expense 7.28
Net Profit -5.66
Net Profit Margin (%) -566.00
Earnings Per Share (EPS) -1.54
EBITDA -4.05
Effective Tax Rate (%) 3.57
Particulars MAR 2022 (Values in Cr)
Revenue 0.39
Operating Expense 3.12
Net Profit -0.83
Net Profit Margin (%) -212.82
Earnings Per Share (EPS) -0.24
EBITDA -1.04
Effective Tax Rate (%) 67.57
Particulars MAR 2021 (Values in Cr)
Revenue 1.27
Operating Expense 5.27
Net Profit -2.01
Net Profit Margin (%) -158.26
Earnings Per Share (EPS) -0.54
EBITDA -1.52
Effective Tax Rate (%) 47.24
Particulars MAR 2025 (Values in Cr)
Book Value / Share 7.38
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.18
EBITDA Margin -35.55
Particulars MAR 2024 (Values in Cr)
Book Value / Share 7.56
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.23
EBITDA Margin -31.29
Particulars MAR 2023 (Values in Cr)
Book Value / Share 8.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.31
EBITDA Margin -392.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.64
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.34
EBITDA Margin -282.05
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.93
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.42
EBITDA Margin -120.47
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.73
Total Assets 60.28
Total Liabilities 60.28
Total Equity 45.42
Share Outstanding 6
Price to Book Ratio 1.46
Return on Assets (%) -7.71
Return on Capital (%) -8.8
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 57.97
Total Liabilities 57.97
Total Equity 40.46
Share Outstanding 4
Price to Book Ratio 1.41
Return on Assets (%) -7.78
Return on Capital (%) -9.32
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 56.02
Total Liabilities 56.02
Total Equity 36.70
Share Outstanding 3
Price to Book Ratio 1.03
Return on Assets (%) -10.10
Return on Capital (%) -12.13
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 55.58
Total Liabilities 55.58
Total Equity 35.45
Share Outstanding 3
Price to Book Ratio 0.96
Return on Assets (%) -1.59
Return on Capital (%) -1.85
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 50.85
Total Liabilities 50.85
Total Equity 32.84
Share Outstanding 3
Price to Book Ratio 1.01
Return on Assets (%) -3.94
Return on Capital (%) -4.61
Particulars MAR 2025 (Values in Cr)
Net Income -5.28
Cash from Operations -6.55
Cash from Investing -0.44
Cash from Financing 8.06
Net change in Cash 0.63
Free Cash Flow -6.11
Particulars MAR 2024 (Values in Cr)
Net Income -5.17
Cash from Operations -4.91
Cash from Investing -0.78
Cash from Financing 5.59
Net change in Cash -0.10
Free Cash Flow -4.12
Particulars MAR 2023 (Values in Cr)
Net Income -5.87
Cash from Operations -2.76
Cash from Investing -1.27
Cash from Financing 3.11
Net change in Cash 0.13
Free Cash Flow -1.49
Particulars MAR 2022 (Values in Cr)
Net Income -2.61
Cash from Operations -0.99
Cash from Investing -0.01
Cash from Financing 0.93
Net change in Cash -0.06
Free Cash Flow -0.97
Particulars MAR 2021 (Values in Cr)
Net Income -3.68
Cash from Operations -6.74
Cash from Investing -0.29
Cash from Financing 6.96
Net change in Cash -0.08
Free Cash Flow -6.44
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.77 1.65 243.69 23.12 40.44
BLISS GVS PHARMA LTD 276.25 26.41 2.58 2922.42 105.05 280.20
CIPLA LTD 1309.90 22.25 3.21 105811.45 1165.55 1672.20
FERMENTA BIOTECH LIMITED 311.40 10.36 2.34 916.48 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2335.60 39.34 23.16 39566.47 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 30.58 4.43 243.69 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 570.45 28.52 4.82 1649.21 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8217.20 98.75 25.71 20543.00 7630.00 10653.05
BLISS GVS PHARMA LTD 276.25 37.64 2.64 2922.42 105.05 280.20

VISTA PHARMACEUTICALS LTD. shareholding pattern

Holding
78.79%
21.18%
0.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

VISTA PHARMACEUTICALS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
7.90 -0.62 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 7.90
  • 26 Days 7.50
  • 10 Days 7.80
  • 50 Days 7.40
  • 12 Days 7.70
  • 100 Days 7.70
  • 20 Days 7.60
  • 200 Days 8.50
7.43 PIVOT
First Support 6.78 First Resistance 7.93 Second Support 6.28 Second Resistance 8.58 Third Support 5.63 Third Resistance 9.08
RSI 54.96 ADX 27.08 MACD 0.20 Williams % R -40.70 Commodity Channel Index (CCI) 9.03
Date 2026-04-30 Week 6617.00 Same Day 5875.00 Month 8158.00
1 Year 0.87 3 Year 0.61
Over 1 Month
26.67% down
Over 1 Year
-28.66% down
Over 3 Months
7.50% down
Over 3 Years
-7.12% down
Over 6 Months
-19.54% down
Over 5 Years
-10.31% down

VISTA PHARMACEUTICALS LTD. Corporate Actions

Ex-Date Old FV NEW FV Record Date
25 Jun 2015 10.0 2.0 26 Jun 2015

Top Gainers

Top Losers

VISTA PHARMACEUTICALS LTD. Share Price

Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & had obtained Certificate of Commencement of Business on February 7, 1991. The Company is engaged in the formulation of pharmaceutical products. It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India.

The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum. Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.

The Company was founded in 1992 to Formulate, Register, Produce, Market and Distribute High Quality Pharmaceutical Products, initially focusing on the United States Market of expanding Globally. It is the first Indian Company to obtain USFDA Approvals to produce OTC as well as Prescription Drugs to US Market in 1994. It is the first Indian Company to export OTC as well as Prescription Drugs to US in 1996.

The Company's Indian Facility got USFDA Approval in June 2010 to produce ANDA products to US Market. It established an extensive Marketing and Distribution Network in the United States. The Company operations are going on as per USFDA cGMP norms. The validations and stability testing studies are going on as per schedules. Its state-of-the-art Facility in India is built according to cGMP and US-FDA standards.

Parent organization Indian Private
NSE symbol [-]
Founded 1991
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Vista Pharmaceuticals Ltd?

Answer Field

Vista Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 7.90 as on May 07 2026 02:38 PM.

What is the Market Cap of Vista Pharmaceuticals Ltd Share?

Answer Field

The market cap of Vista Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 48.60 as on May 07 2026 02:38 PM.

What is the 52 Week High and Low of Vista Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Vista Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 12.01 and ₹ 5.71.

What is 1 year return for Vista Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -24.99%.

What is the P/E Ratio of Vista Pharmaceuticals Ltd Share?

Answer Field

As on May 07 2026 02:38 PM the price-to-earnings (PE) ratio for Vista Pharmaceuticals Ltd share is -6.36.

What is the PB ratio of Vista Pharmaceuticals Ltd Share?

Answer Field

As on May 07 2026 02:38 PM, the price-to-book (PB) ratio for Vista Pharmaceuticals Ltd share is 7.25.

How to Buy Vista Pharmaceuticals Ltd Share?

Answer Field

You can trade in Vista Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vista Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Vista Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vista Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|